La Jolla, CA, United States of America

Michael T White

This inventor holds 1 USPTO granted patent. Top assignee: Myelos Corporation. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael T White. Retrieved from https://idiyas.com/inventor/michael-t-white-kajlw5q0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael T White: Innovator in Neurotrophic Peptides

Introduction

Michael T White is a prominent inventor based in La Jolla, California. He has made significant contributions to the field of neurotrophic and analgesic peptides. His work focuses on developing innovative solutions for treating central and peripheral nervous system disorders.

Latest Patents

Michael T White holds a patent for "Retro-inverso neurotrophic and analgesic peptides." This patent involves retro-inverso peptide analogs derived from the active neurotrophic region of saposin C. The saposin C-derived peptides, known as prosaptides, induce neurite outgrowth in vitro, prevent programmed cell death, induce myelination, and have an analgesic effect. These peptides are particularly useful in pain management and the treatment of various nervous system disorders. Notably, the retro-inverso peptides are significantly more resistant to metabolic degradation than their non-inverted counterparts. He has 1 patent to his name.

Career Highlights

Michael T White is associated with Myelos Corporation, where he continues to advance his research and development efforts. His work has the potential to impact the medical field significantly, particularly in the areas of neurology and pain management.

Collaborations

Some of his notable coworkers include John S O'Brien and David Erick Wright. Their collaboration enhances the innovative environment at Myelos Corporation, fostering advancements in peptide research.

Conclusion

Michael T White is a key figure in the development of neurotrophic peptides, with a focus on improving treatments for nervous system disorders. His innovative work at Myelos Corporation continues to pave the way for future advancements in this critical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…